Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

Ceribell, Inc. (CBLL)

Chao Xingjuan — Director
Jun 8, 2026
Sale
Shares
14,000
Price
$18.33
Total Value
$256.62K
Shares Held After
816,317
% of Holdings
1.7%

LABCORP HOLDINGS INC. (LH)

Kyle Kathryn W — EVP, Chief Legal Officer
Jun 8, 2026
Sale
Shares
762
Price
$263.89
Total Value
$201.08K
Shares Held After
3,813
% of Holdings
16.7%

Indivior Pharmaceuticals, Inc. (INDV)

Preblick Ryan — Chief Financial Officer
Jun 8, 2026
Sale
Shares
36,000
Price
$37.70
Total Value
$1.36M
Shares Held After
284,751
% of Holdings
11.2%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Jun 8, 2026
Sale
Shares
1,567
Price
$95.12
Total Value
$149.05K
Shares Held After
44,788
% of Holdings
3.4%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Jun 8, 2026
Sale
Shares
1,175
Price
$93.95
Total Value
$110.39K
Shares Held After
46,355
% of Holdings
2.5%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Jun 8, 2026
Sale
Shares
2,258
Price
$92.84
Total Value
$209.63K
Shares Held After
47,530
% of Holdings
4.5%
Jun 8, 2026
Sale
Shares
24,428
Price
$5.43
Total Value
$132.63K
Shares Held After
1,405,995
% of Holdings
1.7%

ABEONA THERAPEUTICS INC. (ABEO)

Vasanthavada Madhav — Chief Commercial Officer
Jun 8, 2026
Sale
Shares
4,170
Price
$5.43
Total Value
$22.64K
Shares Held After
308,901
% of Holdings
1.3%

ABEONA THERAPEUTICS INC. (ABEO)

Vazzano Joseph Walter — Chief Financial Officer
Jun 8, 2026
Sale
Shares
10,271
Price
$5.43
Total Value
$55.77K
Shares Held After
557,504
% of Holdings
1.8%

ABEONA THERAPEUTICS INC. (ABEO)

O'Malley Brendan M. — SVP, Chief Legal Officer
Jun 8, 2026
Sale
Shares
4,826
Price
$5.43
Total Value
$26.20K
Shares Held After
446,308
% of Holdings
1.1%

NEXGEL, INC. (NXGL)

Levy Adam R. — Director
Jun 8, 2026
Sale
Shares
3,000
Price
$0.55
Total Value
$1.64K
Shares Held After
336,692
% of Holdings
0.9%

FRACTYL HEALTH, INC. (GUTS)

Smith Weber Lara — Chief Financial Officer
Jun 8, 2026
Purchase
Shares
20,000
Price
$0.69
Total Value
$13.71K
Shares Held After
20,000
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
80
Price
$551.75
Total Value
$44.14K
Shares Held After
18,876
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
610
Price
$551.28
Total Value
$336.28K
Shares Held After
18,956
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
1,285
Price
$550.09
Total Value
$706.87K
Shares Held After
19,566
% of Holdings
6.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
425
Price
$549.38
Total Value
$233.49K
Shares Held After
20,851
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
2,158
Price
$547.91
Total Value
$1.18M
Shares Held After
21,276
% of Holdings
9.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
1,888
Price
$547.03
Total Value
$1.03M
Shares Held After
23,434
% of Holdings
7.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
1,989
Price
$546.13
Total Value
$1.09M
Shares Held After
25,322
% of Holdings
7.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 8, 2026
Sale
Shares
1,565
Price
$544.93
Total Value
$852.82K
Shares Held After
27,311
% of Holdings
5.4%
Jun 8, 2026
Sale
Shares
1,026
Price
$37.77
Total Value
$38.75K
Shares Held After
147,751
% of Holdings
0.7%
Jun 8, 2026
Sale
Shares
1,671
Price
$36.80
Total Value
$61.49K
Shares Held After
148,777
% of Holdings
1.1%
Jun 8, 2026
Sale
Shares
7,003
Price
$36.25
Total Value
$253.85K
Shares Held After
150,448
% of Holdings
4.4%
Shares
5,000
Price
$11.65
Total Value
$58.25K
Shares Held After
5,000
% of Holdings
100.0%
Jun 8, 2026
Purchase
Shares
2,000
Price
$16.94
Total Value
$33.88K
Shares Held After
24,500
% of Holdings
8.2%

Butterfly Network, Inc. (BFLY)

Cashman Steve — Chief Business Officer
Jun 8, 2026
Sale
Shares
294,680
Price
$4.66
Total Value
$1.37M
Shares Held After
1,630,407
% of Holdings
15.3%
Jun 8, 2026
Purchase
Shares
25,000
Price
$1.75
Total Value
$43.73K
Shares Held After
2,600,000
% of Holdings
1.0%
Jun 8, 2026
Sale
Shares
640
Price
$551.37
Total Value
$352.88K
Shares Held After
40,513
% of Holdings
1.6%
Jun 8, 2026
Sale
Shares
650
Price
$550.40
Total Value
$357.76K
Shares Held After
41,153
% of Holdings
1.6%
Jun 8, 2026
Sale
Shares
948
Price
$549.58
Total Value
$521.01K
Shares Held After
41,803
% of Holdings
2.2%
Jun 8, 2026
Sale
Shares
2,144
Price
$547.93
Total Value
$1.17M
Shares Held After
42,751
% of Holdings
4.8%
Jun 8, 2026
Sale
Shares
1,525
Price
$547.07
Total Value
$834.28K
Shares Held After
44,895
% of Holdings
3.3%
Jun 8, 2026
Sale
Shares
2,131
Price
$546.13
Total Value
$1.16M
Shares Held After
46,420
% of Holdings
4.4%
Jun 8, 2026
Sale
Shares
1,462
Price
$544.89
Total Value
$796.63K
Shares Held After
48,551
% of Holdings
2.9%

Century Therapeutics, Inc. (IPSC)

Russotti Gregory — Chief Technology and Manufacturing Officer
Jun 8, 2026
Sale
Shares
524
Price
$2.11
Total Value
$1.11K
Shares Held After
514,903
% of Holdings
0.1%
Jun 8, 2026
Sale
Shares
1,560
Price
$2.15
Total Value
$3.35K
Shares Held After
16,473
% of Holdings
8.7%

Century Therapeutics, Inc. (IPSC)

Carr Douglas — SVP Finance & Operations
Jun 8, 2026
Sale
Shares
249
Price
$2.11
Total Value
$525.64
Shares Held After
506,748
% of Holdings
0.0%
Jun 8, 2026
Sale
Shares
15,000
Price
$4.46
Total Value
$66.84K
Shares Held After
171,889
% of Holdings
8.0%

Medtronic plc (MDT)

KIIL HARRY SKIP — EVP & President Cardiovascular
Jun 8, 2026
Sale
Shares
228
Price
$80.45
Total Value
$18.34K
Shares Held After
37,227
% of Holdings
0.6%

Medtronic plc (MDT)

KIIL HARRY SKIP — EVP & President Cardiovascular
Jun 8, 2026
Sale
Shares
3,961
Price
$80.44
Total Value
$318.62K
Shares Held After
37,455
% of Holdings
9.6%
Jun 8, 2026
Purchase
Shares
2,261,118
Price
$0.11
Total Value
$239.68K
Shares Held After
2,647,299
% of Holdings
85.4%

RESMED INC (RMD)

Farrell Michael J. — Director
Jun 8, 2026
Sale
Shares
4,991
Price
$193.96
Total Value
$968.06K
Shares Held After
466,256
% of Holdings
1.1%

UroGen Pharma Ltd. (URGN)

Schoenberg Mark — Chief Medical Officer
Jun 8, 2026
Sale
Shares
5,222
Price
$27.30
Total Value
$142.56K
Shares Held After
139,763
% of Holdings
3.6%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Jun 8, 2026
Purchase
Shares
2,400
Price
$1.12
Total Value
$2.69K
Shares Held After
133,325
% of Holdings
1.8%
Jun 8, 2026
Sale
Shares
60,547
Price
$0.40
Total Value
$24.22K
Shares Held After
377,211
% of Holdings
13.8%
Jun 5, 2026
Purchase
Shares
5,045
Price
$1.57
Total Value
$7.92K
Shares Held After
69,553
% of Holdings
7.3%
Jun 5, 2026
Purchase
Shares
49,966
Price
$1.57
Total Value
$78.45K
Shares Held After
688,926
% of Holdings
7.3%

Metagenomi Therapeutics, Inc. (MGX)

Wapnick Pamela — Chief Financial Officer
Jun 5, 2026
Sale
Shares
2,884
Price
$1.30
Total Value
$3.75K
Shares Held After
208,491
% of Holdings
1.4%

Metagenomi Therapeutics, Inc. (MGX)

Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Jun 5, 2026
Sale
Shares
558
Price
$1.30
Total Value
$724.84
Shares Held After
126,491
% of Holdings
0.4%
Jun 5, 2026
Sale
Shares
3,737
Price
$1.30
Total Value
$4.85K
Shares Held After
377,533
% of Holdings
1.0%
Version: v26.5.2